Dated laboratory, service, and regulatory notes—with updates called out when the underlying information changes.
Current as of August 26, 2026: Florida's 7-OH limits, 100:1 mitragynine ratio, labeling rules, federal requirements, and the updated Test Code 814 reporting approach.
Read moreEffective August 26, 2026, DEA's temporary order places mitragynine pseudoindoxyl, MGM-15, and MGM-16 in Schedule I through August 26, 2028, subject to possible extension.
Read morePart Number 801 (7-Hydroxymitragynine Relative Alkaloid Ratio) supports reporting against Utah's effective ratio-based 7-OH framework.
Read moreHistorical update: Florida's former 400 ppm (0.04%) dry-weight framework was replaced in July 2026. Test Code 813 is no longer a standard catalog option.
Read more